CN117865871A - Light and organic co-catalysis synthesis of alpha- (2 or 3-indole) ketone derivative and application thereof - Google Patents
Light and organic co-catalysis synthesis of alpha- (2 or 3-indole) ketone derivative and application thereof Download PDFInfo
- Publication number
- CN117865871A CN117865871A CN202311497071.2A CN202311497071A CN117865871A CN 117865871 A CN117865871 A CN 117865871A CN 202311497071 A CN202311497071 A CN 202311497071A CN 117865871 A CN117865871 A CN 117865871A
- Authority
- CN
- China
- Prior art keywords
- nmr
- chloroform
- methyl
- indole
- hrms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000002576 ketones Chemical class 0.000 title claims abstract description 10
- 230000015572 biosynthetic process Effects 0.000 title description 5
- 238000003786 synthesis reaction Methods 0.000 title description 5
- 238000006555 catalytic reaction Methods 0.000 title description 3
- 238000000034 method Methods 0.000 claims abstract description 13
- -1 3-indolyl Chemical group 0.000 claims abstract description 9
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 8
- 229910052736 halogen Inorganic materials 0.000 claims abstract description 7
- 150000002367 halogens Chemical class 0.000 claims abstract description 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims abstract description 7
- BHNHHSOHWZKFOX-UHFFFAOYSA-N 2-metylindole Natural products C1=CC=C2NC(C)=CC2=C1 BHNHHSOHWZKFOX-UHFFFAOYSA-N 0.000 claims abstract description 6
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims abstract description 6
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims abstract description 5
- 238000005859 coupling reaction Methods 0.000 claims abstract description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 3
- 239000001257 hydrogen Substances 0.000 claims abstract description 3
- 150000003254 radicals Chemical class 0.000 claims abstract description 3
- 125000000547 substituted alkyl group Chemical group 0.000 claims abstract description 3
- 150000001875 compounds Chemical class 0.000 claims description 21
- 238000006243 chemical reaction Methods 0.000 claims description 13
- 238000002360 preparation method Methods 0.000 claims description 11
- 235000002566 Capsicum Nutrition 0.000 claims description 10
- 241000196324 Embryophyta Species 0.000 claims description 10
- FGFUBBNNYLNVLJ-UHFFFAOYSA-N indol-3-one Chemical class C1=CC=C2C(=O)C=NC2=C1 FGFUBBNNYLNVLJ-UHFFFAOYSA-N 0.000 claims description 10
- 241000223218 Fusarium Species 0.000 claims description 8
- 239000006002 Pepper Substances 0.000 claims description 8
- 235000016761 Piper aduncum Nutrition 0.000 claims description 8
- 235000017804 Piper guineense Nutrition 0.000 claims description 8
- 235000008184 Piper nigrum Nutrition 0.000 claims description 8
- 235000021307 Triticum Nutrition 0.000 claims description 8
- 230000001580 bacterial effect Effects 0.000 claims description 8
- 201000010099 disease Diseases 0.000 claims description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 8
- 241000607479 Yersinia pestis Species 0.000 claims description 7
- 241000238631 Hexapoda Species 0.000 claims description 6
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 claims description 5
- 241000228197 Aspergillus flavus Species 0.000 claims description 5
- 239000011941 photocatalyst Substances 0.000 claims description 5
- 241000233866 Fungi Species 0.000 claims description 4
- 240000007594 Oryza sativa Species 0.000 claims description 4
- 235000007164 Oryza sativa Nutrition 0.000 claims description 4
- 235000009754 Vitis X bourquina Nutrition 0.000 claims description 4
- 235000012333 Vitis X labruscana Nutrition 0.000 claims description 4
- 240000006365 Vitis vinifera Species 0.000 claims description 4
- 235000014787 Vitis vinifera Nutrition 0.000 claims description 4
- QWXYZCJEXYQNEI-OSZHWHEXSA-N intermediate I Chemical compound COC(=O)[C@@]1(C=O)[C@H]2CC=[N+](C\C2=C\C)CCc2c1[nH]c1ccccc21 QWXYZCJEXYQNEI-OSZHWHEXSA-N 0.000 claims description 4
- HZVOZRGWRWCICA-UHFFFAOYSA-N methanediyl Chemical compound [CH2] HZVOZRGWRWCICA-UHFFFAOYSA-N 0.000 claims description 4
- 235000009566 rice Nutrition 0.000 claims description 4
- 241000233614 Phytophthora Species 0.000 claims description 3
- 241000233622 Phytophthora infestans Species 0.000 claims description 3
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 3
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 claims description 3
- 239000003054 catalyst Substances 0.000 claims description 3
- 244000298697 Actinidia deliciosa Species 0.000 claims description 2
- 235000009436 Actinidia deliciosa Nutrition 0.000 claims description 2
- 208000035143 Bacterial infection Diseases 0.000 claims description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 2
- 241000207199 Citrus Species 0.000 claims description 2
- 240000008067 Cucumis sativus Species 0.000 claims description 2
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 claims description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 2
- 229920002752 Konjac Polymers 0.000 claims description 2
- 244000061176 Nicotiana tabacum Species 0.000 claims description 2
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims description 2
- 241001558929 Sclerotium <basidiomycota> Species 0.000 claims description 2
- 240000000851 Vaccinium corymbosum Species 0.000 claims description 2
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims description 2
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims description 2
- 235000021014 blueberries Nutrition 0.000 claims description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 2
- 229910052794 bromium Inorganic materials 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- 239000000460 chlorine Substances 0.000 claims description 2
- 235000020971 citrus fruits Nutrition 0.000 claims description 2
- 230000008878 coupling Effects 0.000 claims description 2
- 238000010168 coupling process Methods 0.000 claims description 2
- 229910052731 fluorine Inorganic materials 0.000 claims description 2
- 239000011737 fluorine Substances 0.000 claims description 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 2
- 235000010485 konjac Nutrition 0.000 claims description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- 125000001424 substituent group Chemical group 0.000 claims description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 2
- 244000203593 Piper nigrum Species 0.000 claims 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical compound C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims 2
- 241000123650 Botrytis cinerea Species 0.000 claims 1
- 241000221662 Sclerotinia Species 0.000 claims 1
- 244000098338 Triticum aestivum Species 0.000 claims 1
- SMWDFEZZVXVKRB-UHFFFAOYSA-N anhydrous quinoline Natural products N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 claims 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims 1
- 229930192474 thiophene Natural products 0.000 claims 1
- ZFRKQXVRDFCRJG-UHFFFAOYSA-N skatole Chemical compound C1=CC=C2C(C)=CNC2=C1 ZFRKQXVRDFCRJG-UHFFFAOYSA-N 0.000 abstract description 6
- PDSPNGGVEIUMHV-UHFFFAOYSA-N 2-methylindole Chemical compound C1=C[CH]C2=NC(C)=CC2=C1 PDSPNGGVEIUMHV-UHFFFAOYSA-N 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 238000005481 NMR spectroscopy Methods 0.000 description 71
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 67
- 239000011734 sodium Substances 0.000 description 40
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 27
- 238000002844 melting Methods 0.000 description 19
- 230000008018 melting Effects 0.000 description 19
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 10
- 241000209140 Triticum Species 0.000 description 7
- 241000233616 Phytophthora capsici Species 0.000 description 6
- 240000003889 Piper guineense Species 0.000 description 5
- 238000004440 column chromatography Methods 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 238000012544 monitoring process Methods 0.000 description 5
- 239000003208 petroleum Substances 0.000 description 5
- 241000221696 Sclerotinia sclerotiorum Species 0.000 description 4
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 4
- 239000000575 pesticide Substances 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 239000005730 Azoxystrobin Substances 0.000 description 3
- 241000223195 Fusarium graminearum Species 0.000 description 3
- WFDXOXNFNRHQEC-GHRIWEEISA-N azoxystrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1OC1=CC(OC=2C(=CC=CC=2)C#N)=NC=N1 WFDXOXNFNRHQEC-GHRIWEEISA-N 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 150000002475 indoles Chemical class 0.000 description 3
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 description 2
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 description 2
- DFQQXPNVHDJISQ-UHFFFAOYSA-N 1-(1-methylindol-3-yl)propan-2-one Chemical compound C1=CC=C2C(CC(=O)C)=CN(C)C2=C1 DFQQXPNVHDJISQ-UHFFFAOYSA-N 0.000 description 2
- ADLVDYMTBOSDFE-UHFFFAOYSA-N 5-chloro-6-nitroisoindole-1,3-dione Chemical compound C1=C(Cl)C([N+](=O)[O-])=CC2=C1C(=O)NC2=O ADLVDYMTBOSDFE-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 229940125773 compound 10 Drugs 0.000 description 2
- 229940125797 compound 12 Drugs 0.000 description 2
- 238000001212 derivatisation Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 244000053095 fungal pathogen Species 0.000 description 2
- 125000001041 indolyl group Chemical group 0.000 description 2
- KXUHSQYYJYAXGZ-UHFFFAOYSA-N isobutylbenzene Chemical compound CC(C)CC1=CC=CC=C1 KXUHSQYYJYAXGZ-UHFFFAOYSA-N 0.000 description 2
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 2
- JBLLRCOZJMVOAE-HSQYWUDLSA-N n-[(2s)-1-[[(2s)-1-(1,3-benzothiazol-2-yl)-1-oxo-3-[(3s)-2-oxopyrrolidin-3-yl]propan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]-4-methoxy-1h-indole-2-carboxamide Chemical compound C([C@H](NC(=O)[C@H](CC(C)C)NC(=O)C=1NC=2C=CC=C(C=2C=1)OC)C(=O)C=1SC2=CC=CC=C2N=1)[C@@H]1CCNC1=O JBLLRCOZJMVOAE-HSQYWUDLSA-N 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- VIMMECPCYZXUCI-MIMFYIINSA-N (4s,6r)-6-[(1e)-4,4-bis(4-fluorophenyl)-3-(1-methyltetrazol-5-yl)buta-1,3-dienyl]-4-hydroxyoxan-2-one Chemical compound CN1N=NN=C1C(\C=C\[C@@H]1OC(=O)C[C@@H](O)C1)=C(C=1C=CC(F)=CC=1)C1=CC=C(F)C=C1 VIMMECPCYZXUCI-MIMFYIINSA-N 0.000 description 1
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 description 1
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 description 1
- 125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 description 1
- 125000004207 3-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(OC([H])([H])[H])=C1[H] 0.000 description 1
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 description 1
- 125000004199 4-trifluoromethylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C(F)(F)F 0.000 description 1
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 1
- 241000235349 Ascomycota Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- 241000222199 Colletotrichum Species 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- 206010061217 Infestation Diseases 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 241000758706 Piperaceae Species 0.000 description 1
- 238000012271 agricultural production Methods 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 125000005336 allyloxy group Chemical group 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 229940054051 antipsychotic indole derivative Drugs 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 244000000005 bacterial plant pathogen Species 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 1
- 229910000024 caesium carbonate Inorganic materials 0.000 description 1
- 239000001390 capsicum minimum Substances 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000004913 cyclooctene Substances 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000005624 indolones Chemical class 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229960005222 phenazone Drugs 0.000 description 1
- 244000000003 plant pathogen Species 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229940126672 traditional medicines Drugs 0.000 description 1
Landscapes
- Indole Compounds (AREA)
Abstract
The invention discloses a- (2 or 3-indolyl) ketone derivative, which is represented by the following general formula (1):wherein the method comprises the steps of,R 1 Is hydrogen, halogen, methyl or methoxy, R 2 Is alkyl or substituted alkyl, R 3 Is alkyl, aromatic heterocycle or substituted phenyl. The 2 or 3-methylindole and the acyl imidazole disclosed by the invention undergo a free radical coupling reaction to prepare the a- (2 or 3-indolyl) ketone derivative, and the derivative has good universality and good yield which is up to 88%.
Description
Technical Field
The invention relates to a preparation method for synthesizing an alpha- (2 or 3-indole) ketone derivative by catalyzing light and an azacyclo-carbene organic small molecule and a derivatization research.
Background
In recent years, plant fungi and bacteria seriously affect the yield and quality of crops worldwide, and plant fungi diseases directly cause the yield and quality reduction of crops, thereby bringing great economic loss to farmers. For example, gibberella wheat (gibberella zeae. Retch) is a filamentous ascomycete that is a disease that occurs on wheat caused by multiple fusarium infestations. The germ can cause seedling rot, stem basal rot, stem rot and spike rot of wheat, and brings at least 10-20% yield reduction to the country where the wheat is planted each year. Furthermore, phytophthora capsici (Phytophthora capsici) is a pathogenic fungus of the genus Phytophthora subgenera. The germ cyst stems branch irregularly or umbrella, which brings at least a dollar loss of 1 million to the country each year. The pepper anthracnose (Colletotrichum capsicum) can cause pepper rot, which affects the yield of peppers worldwide. In the agricultural production process, plant pathogenic bacteria are made to have a certain resistance to the traditional medicines due to the long-term use of the medicines. Therefore, the creation of a novel efficient, low-toxicity and safe green pesticide has very important significance
Indole skeletons are often found in natural and unnatural compounds, with good biological activity. Various molecules containing indole nucleus have been widely studied in terms of antiviral, antibacterial, antifungal, anticancer, and agricultural chemicals. Therefore, the synthesis of indole compounds has received a great deal of attention. The development of a preparation method of the efficient alpha- (2 or 3-indole) ketone derivative has important application value.
Disclosure of Invention
The invention aims to design and synthesize alpha- (2 or 3-indole) ketone derivatives with novel structures and good substrate universality, and further apply the derivatives to agricultural researches.
The technical scheme of the invention is as follows: an alpha- (2 or 3-indolone derivative represented by the following general formula (1):
wherein R is 1 Is hydrogen, halogen, methyl or methoxy, R 2 Is alkyl or substituted alkyl, R 3 Is alkyl, aromatic heterocycle or substituted phenyl.
Preferably, R 2 Is methyl or CH 2 Ph。
Preferably, the substituent of the substituted phenyl which is benzene ring is halogen, methyl, methoxy, trifluoromethyl or nitro.
Preferably, the halogen is fluorine, chlorine or bromine.
The preparation method of the alpha- (2 or 3-indole) ketone derivatives comprises the following steps:
(1) Substituted methylindole reacts with a photocatalyst to obtain an intermediate I;
(2) Removing protons from the intermediate I to obtain an intermediate II;
(3) The acyl imidazole reacts with the carbene catalyst to obtain an intermediate III, and the intermediate III is reduced by a photocatalyst to obtain an intermediate IV;
(4) And (3) performing free radical coupling on the intermediate II and the intermediate IV to obtain an intermediate V, and finally leaving the carbene to obtain the compound 4.
The reaction general formula and the process are as follows:
the derivatives are used for preventing and controlling agricultural diseases and insect pests.
The agricultural plant diseases and insect pests are plant fungi or bacterial diseases.
The agricultural plant diseases and insect pests are wheat fusarium, potato late blight, blueberry root rot, pepper fusarium, rape sclerotium, rape anthracnose, grape base cavity, rice sheath blight, rice bacterial blight, tobacco bacterial wilt, citrus canker, kiwi fruit canker, cucumber bacterial blight, konjak bacterial blight, grape canker, pepper phytophthora and pepper anthracnose.
The invention has the beneficial effects that: the method comprises the steps of taking common 2-or 3-methylindole and modified carboxylic acid as raw materials, synthesizing a series of a- (2-or 3-indolone derivatives through catalysis of N-heterocyclic carbene (NHC), and then performing a series of derivative synthesis on the synthesized products to obtain indole derivatives with biological activity; it was found to have good universality and good conversion. The indole skeleton synthesized by using the organic micromolecule is a brand new and efficient synthesis method of the indolone compounds, has potential application prospects in the aspects of new pesticide creation and green chiral pesticide creation, and provides a brand new solution and synthesis strategy for the development of new structures on pesticides.
Detailed description of the preferred embodiments
General examples
(1) Synthetic route for the preparation of a- (2 or 3-indolone derivatives):
the preparation implementation method and the conditions are as follows:
0.10mmol of substituted 2 or 3-methylindole 1/2, 0.20mmol of substituted acylimidazole 3, 0.02mmol of azacyclo-carbene catalyst, and 0.001mmol of photocatalyst are respectively weighed into a 10mL Schlenk reaction tube equipped with a magnetic stirrer, 0.05mmol of cesium carbonate (Cs 2 CO 3 ) And 2.0mL of acetonitrile as solvent. The bottle cap is covered, and the mixture is placed in a blue light reactor to be fully stirred for reaction for 12 hours. After the TLC monitoring reaction is finished, separating by column chromatography, obtaining the target compound by eluting with polar petroleum ether of ethyl acetate=30:1, weighing, calculating the corresponding yield, and characterizing the compound by a melting point instrument, a polarimeter, a nuclear magnetic resonance spectrometer NMR and a high resolution mass spectrometer HRMS.
(2) Derivatization studies on the synthesized a- (2 or 3-indolone derivatives:
the target compound was obtained, the corresponding yield was calculated after weighing, and the compound was characterized by a melting point apparatus, polarimeter, nuclear magnetic resonance NMR, high resolution mass spectrometer HRMS.
Process for the preparation by conversion of compounds
Process for the preparation of compound 5h to compound 9
A10.0 mL clean bottle equipped with a magnetic stirrer was charged with 37.45mg of 5h in 1.0mL dibutyl ether and 13 μLTfOH was added for 4 hours at room temperature. After the TLC monitoring, the reaction was quenched by adding sodium bicarbonate, extracted three times with ethyl acetate, dried, spun-dried, and separated by column chromatography, eluting with polar petroleum ether, ethyl acetate=20:1 to give the target compound 9 in 75% yield.
Process for the preparation of compound 5h to compound 10
A10.0 mL clean bottle equipped with a magnetic stirrer was charged with 37.45mg of 5h in 1.0mL of toluene and reacted for 24 hours at room temperature with 40. Mu.LMsOH. After the TLC monitoring reaction was completed, the reaction was quenched by adding sodium bicarbonate, extracted three times with ethyl acetate, dried, spun-dried, and separated by column chromatography, eluting with polar petroleum ether, ethyl acetate=20:1 to yield the target compound 10, 36%.
Process for the preparation of compound 4u to compound 11
A10.0 mL clean bottle equipped with a magnetic stirrer was charged with 37.45mg of 4u in 1.0mL of toluene, and 7mg of D-CSA was added thereto and reacted at room temperature for 60 hours at 60 ℃. After the TLC monitoring, the reaction was quenched by adding sodium bicarbonate, extracted three times with ethyl acetate, dried, spun-dried, and separated by column chromatography, eluting with polar petroleum ether, ethyl acetate=20:1 to give the target compound 11 in 59% yield.
Process for the preparation of compound 4a to compound 12
A10.0 mL clean bottle equipped with a magnetic stirrer was charged with 37.45mg of 4u in 1.0mL of toluene, and 14mg of D-CSA was added thereto and reacted at room temperature for 24 hours at 60 ℃. After the TLC monitoring reaction was completed, the reaction was quenched by adding sodium bicarbonate, extracted three times with ethyl acetate, dried, spun-dried, and separated by column chromatography, eluting with polar petroleum ether, ethyl acetate=20:1 to yield the target compound 12, 64% yield.
The synthetic compounds were experimentally characterized as follows: 1- (4-methoxyphenyl) -2- (1-methyl-1H-2-indol) one (4 a)
Yield; 21mg; melting point: 175-177 ℃.
1 H NMR(400MHz,Chloroform-d)δ8.06–8.03(m,2H),7.55–7.52(m,1H),7.30–7.28(m,1H),7.21–7.16(m,1H),7.09–7.05(m,1H),6.95–6.92(m,2H),6.36(d,J=0.8Hz,1H),4.41(s,2H),3.87(s,3H),3.69(s,3H).
13 C NMR(101MHz,Chloroform-d)δ194.4,163.8,137.7,133.8,131.0,129.3,127.7,121.2,120.1,119.4,113.9,109.1,102.0,55.5,37.6,30.0.
HRMS(ESI-TOF,m/z):Mass calcd.for C 18 H 17 NO 2 + [M+Na] + ,302.1152;found:302.1149.
1- (4-tert-butylphenyl) -2- (1-methyl-1H-2-indole) (4 c)
Yield; 27mg; melting point: 158-160 ℃.
1 H NMR(400MHz,Chloroform-d)δ8.03–8.00(m,2H),7.57–7.49(m,3H),7.30(dd,J=8.2,1.0Hz,1H),7.22–7.18(m,1H),7.11–7.07(m,1H),6.40(s,1H),4.45(s,2H),3.70(s,3H),1.36(s,9H).
13 C NMR(101MHz,Chloroform-d)δ195.4,157.3,137.7,133.6,133.6,128.6,127.7,125.7,121.2,120.1,119.4,109.1,102.0,37.7,35.2,31.0,30.0.
HRMS(ESI-TOF,m/z):Mass calcd.for C 21 H 23 NONa + [M+Na] + ,328.1672;found:328.1673.
1- (4-chlorophenyl) -2- (1-methyl-1H-2-indole) (4 d)
A rate; 21mg; melting point: 160-162 ℃.
1 H NMR(400MHz,Chloroform-d)δ8.01–7.97(m,2H),7.54(dt,J=7.8,1.1Hz,1H),7.11–7.07(m,1H),6.37–7.36(m,1H),4.43(d,J=0.8Hz,2H),3.69(s,3H).
13 C NMR(101MHz,Chloroform-d)δ194.7,140.0,137.7,134.4,132.8,130.0,129.1,127.6,121.4,120.2,119.6,109.1,102.2,37.9,30.0.
HRMS(ESI-TOF,m/z):Mass calcd.for C 17 H 14 ClNONa + [M+Na] + ,306.0656;found:306.0655.
1- (4-fluorophenyl) -2- (1-methyl-1H-2-indole) (4 e)
23mg; melting point: 165-167 ℃.
1 H NMR(400MHz,Chloroform-d)δ8.11–8.06(m,2H),7.56–7.53(m,1H),7.30(dd,J=8.2,1.0Hz,1H),7.22–7.12(m,3H),7.11–7.07(m,1H),6.38(s,1H),4.43(s,2H),3.69(s,3H).
13 C NMR(101MHz,Chloroform-d)δ194.3,166.0(d,J=256.0Hz),137.8,133.0,132.6(d,J=4.0Hz),131.3(d,J=9.4Hz),127.7,121.4,120.2,119.6,115.9(d,J=21.9Hz),109.1,102.2,37.8,30.0.
19 F NMR(377MHz,Chloroform-d)δ-104.24.
HRMS(ESI-TOF,m/z):Mass calcd.for C 17 H 14 FNONa + [M+Na] + ,290.0952;found:290.0952.
1- (4-trifluoromethylphenyl) -2- (1-methyl-1H-2-indole) (4 f)
Yield; 24.7mg; melting point: 194-196 ℃.
1 H NMR(400MHz,Chloroform-d)δ8.17–8.14(m,2H),7.75(d,J=8.2Hz,2H),7.55(dt,J=7.8,1.0Hz,1H),7.31(dd,J=8.2,1.0Hz,1H),7.23–7.19(m,1H),7.11–7.07(m,1H),6.38(s,1H),4.48(s,2H),3.70(s,3H).
13 C NMR(101MHz,Chloroform-d)δ194.9,138.8,137.8,134.8(q,J=32.7Hz),132.4,129.0,127.6,125.8(q,J=3.7Hz),123.5(d,J=273.1Hz),121.5,120.3,119.7,109.2,102.4,38.1,30.0.
19 F NMR(377MHz,Chloroform-d)δ-63.18.
HRMS(ESI-TOF,m/z):Mass calcd.for C 18 H 14 F 3 NONa + [M+Na] + ,340.0920;found:340.0918.
2- (1-methyl-1H-2-indol) -1-phenyl-one (4H)
Melting point: 121-123 ℃.
1 H NMR(400MHz,Chloroform-d)δ8.08–8.05(m,2H),7.62–7.47(m,4H),7.31(dd,J=8.4,1.0Hz,1H),7.22–7.18(m,1H),7.11–7.07(m,1H),6.39(s,1H),4.47(s,2H),3.70(s,3H).
13 C NMR(101MHz,Chloroform-d)δ195.8,137.8,136.2,133.5,133.3,128.7,128.6,127.7,121.2,120.2,119.5,109.1,102.1,37.7,30.0.
HRMS(ESI-TOF,m/z):Mass calcd.for C 17 H 15 NONa + [M+Na] + ,272.1046;found:272.1049.
1- (3-methoxyphenyl) -2- (1-methyl-1H-2-indole) (4 i)
A rate; 24mg; melting point: 156-158 ℃.
1 H NMR(400MHz,Chloroform-d)δ7.66(dt,J=7.8,1.2Hz,1H),7.58–7.54(m,2H),7.40(t,J=8.0Hz,1H),7.30(dd,J=8.2,1.0Hz,1H),7.22–7.18(m,1H),7.16–7.07(m,2H),6.39(s,1H),4.45(s,2H),3.86(s,3H),3.69(s,3H).
13 C NMR(101MHz,Chloroform-d)δ195.7,159.9,137.8,137.6,133.3,129.7,127.7,121.2,121.2,120.2,112.0,119.5,112.9,109.1,102.1,55.4,37.8,30.0.
HRMS(ESI-TOF,m/z):Mass calcd.for C 18 H 17 NO 2 Na + [M+Na] + ,302.1152;found:302.1153.
1- (3-chlorophenyl) -2- (1-methyl-1H-2-indole) (4 k)
24.1mg; melting point: 176-178 ℃.
1 H NMR(400MHz,Chloroform-d)δ8.02(t,J=1.8Hz,1H),7.93(dt,J=7.8,1.4Hz,1H),7.57–7.53(m,2H),7.43(t,J=8.0Hz,1H),7.33–7.28(m,1H),7.22–7.18(m,1H),7.10–7.06(m,1H),6.38(s,1H),4.44(s,2H),3.68(s,3H).
13 C NMR(101MHz,Chloroform-d)δ194.6,137.8,137.7,135.2,133.4,132.6,130.1,128.7,127.6,126.7,121.4,120.3,119.6,109.1,102.3,37.8,30.0.
HRMS(ESI-TOF,m/z):Mass calcd.for C 17 H 14 ClNONa + [M+Na] + ,306.0656;found:306.0657.
1- (3-fluorophenyl) -2- (1-methyl-1H-2-indole) (4 l)
22.3mg; melting point: 149-151 ℃.
1 H NMR(400MHz,Chloroform-d)δ7.85(dt,J=7.8,1.2Hz,1H),7.75–7.72(m,1H),7.55(dt,J=7.8,1.2Hz,1H),7.50–7.44(m,1H),7.32–7.27(m,2H),7.18–7.12(m,1H),7.11–7.07(m,1H),6.39(s,1H),4.44(s,2H),3.69(s,3H).
13 C NMR(101MHz,Chloroform-d)δ194.6(d,J=2.7Hz),162.9(d,J=248.5Hz),138.3(d,J=6.5Hz),137.8,132.7,130.5(d,J=7.9Hz),127.7,124.4(d,J=2.9Hz),121.4,120.6(d,J=21.4Hz),120.3,119.6,115.4(d,J=22.4Hz),109.2,102.3,37.9,30.0.
19 F NMR(377MHz,Chloroform-d)δ-111.34.
HRMS(ESI-TOF,m/z):Mass calcd.for C 17 H 14 FNONa + [M+Na] + ,290.0952;found:290.0951.
1- (3-Methylesterphenyl) -2- (1-methyl-1H-2-indole) (4 m)
A rate; 21.4mg; melting point: 182-184 ℃.
1 H NMR(400MHz,Chloroform-d)δ8.72(t,J=1.8Hz,1H),8.27–8.22(m,2H),7.60–7.53(m,2H),7.30(dd,J=8.2,1.0Hz,1H),7.22–7.18(m,1H),7.10–7.06(m,1H),6.40(s,1H),4.51(s,2H),3.97(s,3H),3.70(s,3H).
13 C NMR(101MHz,Chloroform-d)δ195.0,166.1,137.8,136.4,134.2,132.77,132.7,130.9,129.7,129.1,127.7,121.4,120.2,119.5,109.1,102.3,52.4,37.8,30.0.
HRMS(ESI-TOF,m/z):Mass calcd.for C 19 H 17 NO 3 Na + [M+Na] + ,330.1100;found:330.1103.
1- (2-chlorophenyl) -2- (1-methyl-1H-2-indole) (4 o)
12.7mg; melting point: 168-170 ℃.
1 H NMR(400MHz,Chloroform-d)δ7.54(d,J=7.8Hz,1H),7.47–7.37(m,3H),7.32–7.28(m,2H),7.22–7.18(m,1H),7.10–7.06(m,1H),6.37(s,1H),4.47(s,2H),3.70(s,3H).
13 C NMR(101MHz,Chloroform-d)δ198.9,138.66,137.8,132.3,132.0,130.9,130.6,129.3,127.7,127.0,121.4,120.3,119.5,109.2,102.4,41.6,30.0.
HRMS(ESI-TOF,m/z):Mass calcd.for C 17 H 14 ClNONa + [M+Na] + ,306.0656;found:306.0657.
2- (1-methyl-1H-2-indol) -1- (naphtyl) one (4 p)
17.3mg; melting point: 163-165 ℃.
1 H NMR(400MHz,Chloroform-d)δ8.62–8.61(m,1H),8.09(dd,J=8.6,1.8Hz,1H),8.00–7.98(m,1H),7.93–7.88(m,2H),7.65–7.53(m,3H),7.31(dd,J=8.4,1.0Hz,1H),7.22–7.18(m,1H),7.10–7.06(m,1H),6.43(d,J=0.8Hz,1H),4.61(s,2H),3.73(s,3H).
13 C NMR(101MHz,Chloroform-d)δ195.8,137.8,135.8,133.6,133.4,132.5,130.4,129.7,128.8 128.7,127.8,127.7,126.3,124.1,121.3,120.2,119.5,109.1,102.2,37.8,30.1.
HRMS(ESI-TOF,m/z):Mass calcd.for C 21 H 17 NONa + [M+Na] + ,322.1202;found:322.11199.
2- (1-methyl-1H-2-indol) -1- (3-pyridine) one (4 r)
20.7mg; melting point: 127-129 ℃.
1 H NMR(400MHz,Chloroform-d)δ9.29(dd,J=2.4,0.8Hz,1H),8.79(dd,J=4.8,1.8Hz,1H),8.30(dt,J=8.0,2.0Hz,1H),7.54(dt,J=8.0,1.0Hz,1H),7.45–7.41(m 1H),7.31–7.29(m,1H),7.22–7.18(m,1H),7.11–7.07(m,1H),6.40(s,1H),4.47(s,2H),3.70(s,3H).
13 C NMR(101MHz,Chloroform-d)δ194.7,153.8,150.0,137.8,135.9,132.1,131.4,127.6,123.8,121.5,120.3,119.6,109.2,102.4,38.0,30.0.
HRMS(ESI-TOF,m/z):Mass calcd.for C 16 H 15 N 2 O + [M+H] + ,251.1179;found:251.1181.
2- (1-methyl-1H-2-indol) -1- (2-thiophene) one (4 s)
16.8mg; melting point: 99-101 ℃.
1 H NMR(400MHz,Chloroform-d)δ7.83(dd,J=3.8,1.2Hz,1H),7.66(dd,J=5.0,1.2Hz,1H),7.56(dt,J=8.0,1.0Hz,1H),7.31–7.28(m,1H),7.22–7.18(m,1H),7.13(dd,J=5.0,3.8Hz,1H),7.11–7.07(m,1H),6.44(d,J=0.9Hz,1H),4.39(s,1H),4.39(s,2H),3.72(s,3H).
13 C NMR(101MHz,Chloroform-d)δ188.6,143.2,137.8,134.3,133,132.9,128.3,127.6,121.4,120.2,119.6,109.2,102.3,38.8,30.1.
HRMS(ESI-TOF,m/z):Mass calcd.for C 15 H 13 NOSNa + [M+Na] + ,278.0610;found:278.0613.
1- (furan-2-yl) -2- (1-methyl-1H-2-indol) one (4 t)
15.6mg; melting point: 102-104 ℃.
1 H NMR(400MHz,Chloroform-d)δ7.61(dd,J=1.8,0.8Hz,1H),7.54(dt,J=8.0,1.0Hz,1H),7.29(dd,J=8.2,1.0Hz,1H),7.25–7.24(m,1H),7.21–7.17(m,1H),7.10–7.06(m,1H),6.54(dd,J=3.6,1.8Hz,1H),6.43(q,J=0.8Hz,1H),4.32(d,J=0.7Hz,2H),3.72(s,3H).
13 C NMR(101MHz,Chloroform-d)δ184.6,152.0,146.7,137.8,132.7,127.7,121.3,120.2,119.5,118.2,112.6,109.2,102.2,37.5,30.1.
HRMS(ESI-TOF,m/z):Mass calcd.for C 15 H 13 NO 2 Na + [M+Na] + ,262.0839;found:262.0841.
1- (1-methyl-1H-2-indol-2-yl) acetone (4 u)
1 H NMR(400MHz,Chloroform-d)δ7.58(dt,J=8.0,1.0Hz,1H),7.31–7.28(m,1H),7.23–7.19(m,1H),7.13–7.09(m,1H),6.41(d,J=0.8Hz,1H),3.87(s,2H),3.65(s,3H),2.20(s,3H).
13 C NMR(101MHz,Chloroform-d)δ205.0,137.8,133.0,127.7,121.5,120.2,119.7,109.2,102.0,42.9,29.8,28.9.
HRMS(ESI-TOF,m/z):Mass calcd.for C 12 H 14 NO + [M+H] + ,188.1070;found:188.1073.
2- (6-methoxy-1-methyl-1H-2-indol) -1- (4-methoxyphenyl) one (4 ad)
Example I; white solid, 49% yield; 15mg; melting point: 161-162 ℃.
1 H NMR(400MHz,Chloroform-d)δ8.06–8.02(m,2H),7.41–7.39(m,1H),6.96–6.93(m,2H),6.75(d,J=7.8Hz,2H),6.29(d,J=0.8Hz,1H),4.37(d,J=0.8Hz,2H),3.87(s,6H),3.64(s,3H).
13 C NMR(101MHz,Chloroform-d)δ194.6,163.8,156.0,138.4,132.6,130.9,129.3,122.0,120.7,113.9,109.1,101.8,93.1,55.8,55.5,37.6,30.1.
HRMS(ESI-TOF,m/z):Mass calcd.for C 19 H 19 NO 3 Na + [M+Na] + ,332.1257;found:332.1257.
2-methoxy-1- (4-methoxybenzene) -2- (1-methyl-1H-2-indol) one (4 ak)
Yield; 20.5mg; melting point: 123-125 ℃.
1 H NMR(400MHz,Chloroform-d)δ8.07–8.03(m,2H),7.55(dt,J=8.0,1.0Hz,1H),7.32–7.30(m,1H),7.25–7.20(m,1H),7.10–7.06(m,1H),6.89–6.86(m,2H),6.53(s,1H),5.77(s,1H),3.83(s,3H),3.80(s,3H),3.48(s,3H).
13 C NMR(101MHz,Chloroform-d)δ193.8,163.8,138.4,134.1,131.4,128.0,127.1,122.3,120.9,119.7,113.7,109.3,104.5,80.1,57.1,55.4,30.4.
HRMS(ESI-TOF,m/z):Mass calcd.for C 19 H 19 NO 3 + [M+Na] + ,332.1257;found:332.1257.
1- (4-tert-butylphenyl) -2- (1-methyl-1H-3-indol) one (5 b)
21mg。
1 H NMR(400MHz,Chloroform-d)δ8.02–7.99(m,2H),7.62(dt,J=7.8,1.0Hz,1H),7.47–7.45(m,2H),7.30(dt,J=8.2,1.0Hz,1H),7.26–7.21(m,1H),7.16–7.12(m,1H),7.01(d,J=1.0Hz,1H),4.38(d,J=1.0Hz,2H),3.74(s,3H),1.33(s,9H).
13 C NMR(101MHz,Chloroform-d)δ197.5,156.7,136.9,134.1,128.6,127.8,125.5,121.7,119.2,118.9,109.3,107.5,35.31,35.07,32.69,31.06.
HRMS(ESI-TOF,m/z):Mass calcd.for C 21 H 23 NONa + [M+Na] + ,328.1672;found:328.1664.
1- (4- (allyloxy) phenyl) -2- (1-methyl-1H-3-indol) one (5 c)
1 H NMR(400MHz,Chloroform-d)δ8.05–8.01(m,2H),7.61(dt,J=7.8,1.0Hz,1H),7.29(dt,J=8.2,1.0Hz,1H),7.25–7.21(m,1H),7.15–7.11(m,1H),6.98(d,J=1.0Hz,1H),6.94–6.90(m,2H),6.09–5.99(m,1H),5.57–5.25(m,2H),5.42(dq,J=17.4,1.6Hz,1H),5.31(dq,J=10.6,1.4Hz,1H),4.34(d,J=0.4Hz,2H),3.74(s,3H).
13 C NMR(101MHz,Chloroform-d)δ196.6,162.4,136.9,132.5,130.9,129.9,127.8,127.7,121.7,119.1,118.9,118.1,114.4,109.2,107.6,68.9,35.2,32.7.
HRMS(ESI-TOF,m/z):Mass calcd.for C 20 H 19 NO 2 Na + [M+Na] + ,328.1308;found:328.1309.
1- (4-Acetylbenzene) -2- (1-methyl-1H-3-indol) one (5 d)
1 H NMR(400MHz,Chloroform-d)δ8.13–8.10(m,2H),8.01–7.98(m,2H),7.60(dt,J=8.0,1.0Hz,1H),7.30(dt,J=8.2,1.0Hz,1H),7.26–7.22(m,1H),7.16–7.12(m,1H),6.99(d,J=1.0Hz,1H),4.42(d,J=1.0Hz,2H),3.74(s,3H),2.62(s,3H).
13 C NMR(101MHz,Chloroform-d)δ197.5,197.3,140.1,139.9,137.0,128.8,128.5,127.9,127.6,121.9,119.4,118.7,109.4,106.7,35.9,32.7,26.8.
HRMS(ESI-TOF,m/z):Mass calcd.for C 19 H 17 NO 2 Na + [M+Na] + ,314.1152;found:314.1150.
1- (3-Methylesterphenyl) -2- (1-methyl-1H-3-indol) one (5 e)
A rate; 20.3mg.
1 H NMR(400MHz,Chloroform-d)δ8.74(t,J=1.8Hz,1H),8.24–8.19(m,2H),7.63(dt,J=7.8,1.0Hz,1H),7.52(td,J=7.8,0.6Hz,1H),7.30(dt,J=8.4,1.0Hz,1H),7.26–7.22(m,1H),7.16–7.12(m,1H),7.02(d,J=1.0Hz,1H),4.44(d,J=1.0Hz,2H),3.95(s,3H),3.74(s,3H).
13 C NMR(101MHz,Chloroform-d)δ196.9,166.3,136.9,136.8,133.7,132.7,130.6,129.7,128.8,127.9,127.7,121.8,119.2,118.8,109.3,106.7,52.3,35.6,32.7.
HRMS(ESI-TOF,m/z):Mass calcd.for C 19 H 17 NO 3 Na + [M+Na] + ,330.1100;found:330.1102.
2- (1-methyl-1H-3-indol) -1- (2-Neyl-) one (5 f)
1 H NMR(400MHz,Chloroform-d)δ8.62–8.61(m,1H),8.10(dd,J=8.6,1.8Hz,1H),7.96–7.93(m,1H),7.89–7.85(m,2H),7.67(dt,J=7.8,1.0Hz,1H),7.61–7.57(m,1H),7.56–7.52(m,1H),7.30(dt,J=8.2,1.0Hz,1H),7.26–7.22(m,1H),7.18–7.14(m,1H),7.03(d,J=1.0Hz,1H),4.53(d,J=1.0Hz,2H),3.74(s,3H).
13 C NMR(101MHz,Chloroform-d)δ197.9,137.0,135.6,134.1,132.6,130.3,129.6,128.4,127.85,127.8,127.7,126.7,124.4,121.8,119.2,118.9,109.3,107.4,35.5,32.7.
HRMS(ESI-TOF,m/z):Mass calcd.for C 21 H 17 NONa + [M+Na] + ,322.1202;found:322.1203.
1- (1-methyl-1H indol-3-yl) 2-propanone (5H)
1 H NMR(400MHz,Chloroform-d)δ7.53(dt,J=8.0,1.0Hz,1H),7.32(dt,J=8.2,1.0Hz,1H),7.26–7.22(m,1H),7.15–7.11(m,1H),7.00(d,J=1.0Hz,1H),3.81(s,2H),3.78(s,3H),2.17(s,3H).
13 C NMR(101MHz,Chloroform-d)δ207.5,137.0,127.8,127.7,121.9,119.3,119.3,118.8,109.3,107.1,40.7,32.7,28.9.
HRMS(ESI-TOF,m/z):Mass calcd.for C 12 H 13 NONa + [M+Na] + ,210.0889;found:210.0894.
2- (1-benzyl-1H-3-indol) -1- (4-methoxyphenyl) one (5 n)
1 H NMR(400MHz,Chloroform-d)δ8.06–8.00(m,2H),7.65–7.63(m,1H),7.29–7.23(m,4H),7.19–7.13(m,2H),7.11–7.06(m,3H),6.94–6.89(m,2H),5.27(s,2H),4.36(d,J=1.0Hz,2H),3.85(s,3H).
13 C NMR(101MHz,Chloroform-d)δ196.5,163.4,137.5,136.6,130.9,130.4,129.8,128.7,128.1,127.5,127.2,126.8,121.9,119.4,119.0,114.1,113.7,109.8,108.5,55.42,49.99,35.32.
HRMS(ESI-TOF,m/z):Mass calcd.for C 24 H 21 NO 2 Na + [M+Na] + ,378.1455;found:378.1453.
2- (3-ethyl-1-methyl-1H-2-indol-) -1- (4-methylbenzene) one (7 e)
Yield, 16.1mg.
1 H NMR(400MHz,Chloroform-d)δ8.07–8.02(m,2H),7.58(dt,J=8.0,1.0Hz,1H),7.29–7.25(m,2H),7.20–7.16(m,1H),7.10–7.06(m,1H),6.99–6.95(m,2H),4.41(s,2H),3.89(s,3H),3.62(s,3H),2.76(q,J=7.6Hz,2H),1.20(t,J=7.6Hz,3H).
13 C NMR(101MHz,Chloroform-d)δ194.6,163.8,137.2,130.7,129.6,129.3,127.2,121.1,118.6,118.6,115.5,113.9,108.9,55.5,34.9,30.0,17.9,15.8.
HRMS(ESI-TOF,m/z):Mass calcd.for C 20 H 21 NO 2 Na + [M+Na] + ,330.1465;found:330.1464.
3- (4-Isobutylbenzene) -1- (1-methyl-1H-2-indole) 2-butanone (8 e)
1 H NMR(400MHz,Chloroform-d)δ7.56(dt,J=7.8,1.0Hz,1H),7.24–7.17(m,2H),7.13–7.05(m,5H),6.29(s,1H),3.95(q,J=7.0Hz,1H),3.87–3.77(m,2H),3.39(s,3H),2.47(d,J=7.2Hz,2H),1.87(dt,J=13.6,6.8Hz,1H),1.39(d,J=7.0Hz,3H),0.93(dd,J=6.6,1.4Hz,6H).
13 C NMR(101MHz,Chloroform-d)δ207.0,140.9,137.6,137.2,133.1,129.7,127.7,127.7,121.2,120.1,119.5,109.1,102.0,51.1,45.0,40.1,30.2,29.5,22.4,22.3,17.5.
HRMS(ESI-TOF,m/z):Mass calcd.for C 23 H 27 NONa + [M+Na] + ,356.1985;found:356.1981.
3- (4-isobutylbenzene) -1- (1-methyl-1H-3-indole) 2-butanone (8 f)
1 H NMR(400MHz,Chloroform-d)δ7.31(dt,J=7.8,1.0Hz,1H),7.28(dt,J=8.2,1.0Hz,1H),7.22–7.18(m,1H),7.11(s,4H),7.09–7.02(m,1H),6.86(s,1H),3.90(q,J=6.8Hz,1H),3.80–3.69(m,5H),2.47(d,J=7.2Hz,2H),1.87(dt,J=13.6,6.8Hz,1H),1.34(d,J=6.8Hz,3H),0.92(d,J=6.6Hz,6H).
13 C NMR(101MHz,Chloroform-d)δ209.0,140.6,138.0,136.8,129.6,128.0,127.8,127.7,121.7,119.1,118.8,109.2,107.1,51.1,45.0,37.7,32.7,30.2,22.4,17.8.
HRMS(ESI-TOF,m/z):Mass calcd.for C 23 H 27 NONa + [M+Na] + ,356.1985;found:356.1984.
3- (2-fluoro- [1,1' -4-biphenyl) -1- (1-methyl-1H-3-indole) 2-butanone (8H)
1 H NMR(400MHz,Chloroform-d)δ7.55–7.53(m,2H),7.47–7.43(m,2H),7.40–7.35(m,3H),7.30(dt,J=8.4,1.0Hz,1H),7.25–7.21(m,1H),7.12–7.07(m,1H),7.02(dd,J=8.0,1.8Hz,1H),6.96(dd,J=11.6,1.8Hz,1H),6.91(s,1H),3.97(q,J=7.0Hz,1H),3.89–3.77(m,2H),3.76(s,3H),1.39(d,J=7.0Hz,3H).
13 C NMR(101MHz,Chloroform-d)δ208.2,159.8(d,J=248.8Hz),142.1(d,J=7.4Hz),136.9,135.4,131.0(d,J=4.2Hz),128.9(d,J=2.9Hz),128.5,128.0,127.8,127.7,123.9(d,J=3.6Hz),121.8,119.3,118.7,115.6(d,J=23.3Hz),109.3,106.7,50.6,38.3,32.7,17.9.
19 F NMR(377MHz,Chloroform-d)δ-117.39.
HRMS(ESI-TOF,m/z):Mass calcd.for C 25 H 22 FNONa + [M+Na] + ,394.1578;found:394.1572.
5,6,12, 13-tetramethyl-6, 13-cyclooctyl [1,2-b:5,6-b' ] diindole (9)
(m,2H),7.03–6.99(m,2H),3.78(s,6H),3.22–3.10(m,4H),1.91(s,6H).
13 C NMR(101MHz,Chloroform-d)δ137.7,137.5,126.1,121.2,118.9,117.7,108.8,107.0,72.1,34.1,31.3,27.0.
HRMS(ESI-TOF,m/z):Mass calcd.for C 24 H 24 N 2 ONa + [M+Na] + ,379.1781;found:379.1775.
1,3, 9-trimethyl-2- (1-methyl-1H-3-indole) -9H-carbazole (10)
7.29–7.19(m,3H),7.10–7.06(m,1H),6.95(s,1H),4.12(s,3H),3.90(s,3H),2.58(s,3H),2.21(s,3H).
13 C NMR(101MHz,Chloroform-d)δ142.5,139.1,136.8,132.9,129.8,128.3,127.6,125.3,122.9,122.7,121.5,121.1,120.2,119.8,119.1,118.7,118.1,115.2,109.1,108.6,33.0,32.8,21.7,17.4.
HRMS(ESI-TOF,m/z):Mass calcd.for C 24 H 23 N 2 + [M+H] + ,339.1856;found:339.1850.
5,7,12,14-tetramethyl-7, 14-cyclooctyl [1,2-b:5,6-b' ] diindole (11)
6H),3.15–3.01(m,4H),1.99(s,6H).
13 C NMR(101MHz,Chloroform-d)δ137.0,134.4,123.9,120.2,118.8,118.3,112.6,109.0,72.2,34.7,29.0,28.2.
HRMS(ESI-TOF,m/z):Mass calcd.for C 24 H 24 N 2 ONa + [M+Na] + ,379.1781;found:379.1775.
(6Z, 13Z) -7, 14-bis (4-methoxybenzene) -5, 12-dimethyl-5, 12-cyclooctene [1,2-b:5,6-b' ] diindole (12)
(m,4H),7.20(dt,J=8.2,0.8Hz,2H),7.10–7.05(m,2H),6.85–6.80(m,8H),6.70(dt,J=7.8,1.0Hz,2H),3.82(s,6H),3.75(s,6H).
13 C NMR(101MHz,Chloroform-d)δ159.6,144.7,138.1,138.1,134.3,129.1,127.2,121.3,120.5,119.1,117.0,113.9,113.6,108.9,55.3,29.9.
HRMS(ESI-TOF,m/z):Mass calcd.for C 36 H 30 N 2 O 2 Na + [M+Na] + ,545.2199;found:545.2194.
2, 6-4 methylpiperidin-1-yl 4-p-methoxybenzoic acid methyl ester (13)
2H),6.96–6.93(m,2H),3.87(s,3H),1.82–1.63(m,3H),1.60–1.56(m,2H),1.48–1.42(m,1H),1.26(s,6H),1.11(s,6H).
13 C NMR(101MHz,Chloroform-d)δ166.0,163.2,131.4,121.9,113.6,60.2,55.3,38.9,31.8,20.7,16.9.
Pharmacological example 1 application of alpha- (2 or 3-indolyl) ketone derivative to pathogenic fungi resistance the obtained compounds were tested for bacteriostatic activity against phytophthora capsici (p.capsici), gibberella wheat (g.zeae (schw.) Petch), sclerotinia sclerotiorum (s.sclerotiorum) and aspergillus flavus (a.flavus) plant pathogens. The test results show that the target part of the compound has a certain inhibitory activity on the germs at the concentration of 50 mug/mL. For phytophthora capsici (P.capsici), the compounds with better activity comprise 4d,4p,4r,4u and 5b, and the inhibition rate reaches 40-50%. For sclerotinia sclerotiorum (S.sclerotiorum), the compounds have 4u,4ak,4n and 7e, and the inhibition rate reaches 40-60%. Is superior to the control medicine Azoxystrobin (37%). For Aspergillus flavus (A.flavus), the compounds include compounds such as 4e,4m,4p,4u,5c,5e,5n, 8h and the like, and the inhibition rate reaches 40-52%. Is superior to the control Azoxystrobin (34%). For the wheat gibberella (G.zeae (Schw.) Petch), the compounds have compounds of 4h,4i,4k, 4o and the like, and the inhibition rate reaches 50-64%. Is superior to the control medicine Azoxystrobin (41%).
Table one: inhibition rate of target compound alpha- (2 or 3-indolone derivative on plant fungal disease
/>
Claims (10)
1. A class of a- (2 or 3-indole) ketone derivatives is characterized in that: the derivative is represented by the following general formula (1):
wherein R is 1 Is hydrogen, halogen, methyl or methoxy, R 2 Is alkyl or substituted alkyl, R 3 Is alkyl, aromatic heterocycle or substituted phenyl.
2. A class of a- (2 or 3-indolone derivatives according to claim 1, characterized in that: r is R 2 Is methyl or CH 2 Ph。
3. A class of a- (2 or 3-indolone derivatives according to claim 1, characterized in that: the substituent of the substituted phenyl which is a benzene ring is halogen, methyl, methoxy, trifluoromethyl or nitro.
4. A- (2 or 3-indolone derivative according to claim 1 or 3, characterized in that: the halogen is fluorine, chlorine or bromine.
5. A class of a- (2 or 3-indolone derivatives according to claim 1, characterized in that: the aromatic heterocycle is quinoline, pyridine, thiophene and furan.
6. A process for the preparation of the a- (2 or 3-indolone derivatives as claimed in claim 1, wherein: the method comprises the following steps:
(1) Substituted methylindole reacts with a photocatalyst to obtain an intermediate I;
(2) Removing protons from the intermediate I to obtain an intermediate II;
(3) The acyl imidazole reacts with the carbene catalyst to obtain an intermediate III, and the intermediate III is reduced by a photocatalyst to obtain an intermediate IV;
(4) The intermediate II and the intermediate IV are subjected to free radical coupling to obtain an intermediate V, and finally the compound 4 is obtained after the carbene leaves;
the reaction general formula and the process are as follows:
7. use of the derivatives according to any one of claims 1 to 5 for controlling agricultural pests.
8. Use according to claim 7, characterized in that: the agricultural plant diseases and insect pests are plant fungi or bacterial diseases.
9. Use according to claim 8, characterized in that: the agricultural plant diseases and insect pests are phytophthora infestans, botrytis cinerea, aspergillus flavus and sclerotinia rot of rape.
10. Use according to claim 8, characterized in that: the agricultural plant diseases and insect pests are wheat fusarium, potato late blight, blueberry root rot, pepper fusarium, rape sclerotium, rape anthracnose, grape base cavity, rice sheath blight, rice bacterial blight, tobacco bacterial wilt, citrus canker, kiwi fruit canker, cucumber bacterial blight, konjak bacterial blight, grape canker, pepper phytophthora and pepper anthracnose.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311497071.2A CN117865871A (en) | 2023-11-10 | 2023-11-10 | Light and organic co-catalysis synthesis of alpha- (2 or 3-indole) ketone derivative and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311497071.2A CN117865871A (en) | 2023-11-10 | 2023-11-10 | Light and organic co-catalysis synthesis of alpha- (2 or 3-indole) ketone derivative and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117865871A true CN117865871A (en) | 2024-04-12 |
Family
ID=90593412
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311497071.2A Pending CN117865871A (en) | 2023-11-10 | 2023-11-10 | Light and organic co-catalysis synthesis of alpha- (2 or 3-indole) ketone derivative and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117865871A (en) |
-
2023
- 2023-11-10 CN CN202311497071.2A patent/CN117865871A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Sumangala et al. | Synthesis and antimicrobial activity of 1, 2, 3-triazoles containing quinoline moiety | |
Chen et al. | New Synthesis of A‐Ring Aromatic Strigolactone Analogues and Their Evaluation as Plant Hormones in Pea (Pisum sativum) | |
CN112608307B (en) | Heterocyclic substituted 1,3,4-oxadiazole hydrazide compound as well as preparation method and application thereof | |
CN110183373A (en) | A kind of optical activity 1- (hetero) aryl indole derivatives and its preparation method and application | |
Zhou et al. | Synthesis and antifungal activities of novel trifluoroethane derivatives with coumarin, indole and thiophene | |
CN113666859B (en) | Preparation method of azacyclo-substituted trifluoromethyl olefin and Michael addition product thereof | |
CN114805347B (en) | Organic catalytic synthesis chiral pyrazolo [3,4-b ] pyridone compound and application thereof | |
CN117865871A (en) | Light and organic co-catalysis synthesis of alpha- (2 or 3-indole) ketone derivative and application thereof | |
CN114516881B (en) | Azacyclo-carbene catalyzed pyrazolopyran skeleton-containing chiral compound and preparation method thereof | |
CN107868087B (en) | Method for preparing pyrroloindole derivatives | |
CN103864801B (en) | Pyrazole Spirocyclic derivatives and preparation method thereof and fungicide purposes | |
Klochkov et al. | Amination products of Inula britannica lactones and their antitumor activity | |
CN109970704B (en) | Chalcone derivative containing thiophene sulfonate, and preparation method and application thereof | |
CN113603694A (en) | 1, 2-diketone compound and preparation method and application thereof | |
CN103613529B (en) | Pyrrole derivative and preparation method and application thereof | |
CN108276420B (en) | 8, 13-dihydrobenzo [5,6] chromene [2,3-b ] indole compound and synthetic method thereof | |
CN110357804A (en) | A kind of synthetic method of pyrrole carboxylic acid derivative | |
CN112824411B (en) | Bridged ring isoindolinone derivatives, and preparation method and application thereof | |
CN111269237B (en) | Gem-difluorinated spiro-gamma-lactam indoline compound, preparation method thereof and application thereof in preventing and treating plant diseases and insect pests | |
CN115160159B (en) | Halichonin B analogue, preparation method thereof and application thereof in preparing agricultural bactericide | |
CN113402436B (en) | Tertiary amino acid derivative, preparation method and application thereof | |
CN111264542B (en) | Application of gem-difluorinated lactam spirobenzo five-membered nitrogen heterocyclic compound in prevention and treatment of plant diseases and insect pests | |
CN111269180B (en) | Application of compound containing trifluoromethyl indeno benzo six-membered heterocyclic structure in prevention and treatment of plant diseases and insect pests | |
CN117486770A (en) | 2-cyanoacrylate compound and preparation method and application thereof | |
CN116730954A (en) | Isopropanolamine compound containing chalcone structure, and preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |